APA (7th ed.) Citation

Chandrasekaran, V., Samykannu, G., Natarajan, J., & Rangasamy, K. (2025). Revelation of Brevi-inflammin, a novel anti-inflammatory metabolite from Brevibacterium casei VRK 1, as a potent COX-2 inhibitor. Computational biology and chemistry.

Chicago Style (17th ed.) Citation

Chandrasekaran, Vishnupriya, Gopinath Samykannu, Jeykumar Natarajan, and Kavitha Rangasamy. Revelation of Brevi-inflammin, a Novel Anti-inflammatory Metabolite from Brevibacterium Casei VRK 1, as a Potent COX-2 Inhibitor. Computational biology and chemistry, 2025.

MLA (9th ed.) Citation

Chandrasekaran, Vishnupriya, et al. Revelation of Brevi-inflammin, a Novel Anti-inflammatory Metabolite from Brevibacterium Casei VRK 1, as a Potent COX-2 Inhibitor. Computational biology and chemistry, 2025.